To include your compound in the COVID-19 Resource Center, submit it here.

Meritage's oral budesonide meets Phase IIb endpoints

Meritage Pharma Inc. (San Diego, Calif.) said mid- and high-dose oral budesonide suspension

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE